ロード中...
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
Hepatitis C virus (HCV) infects around 71 million people worldwide and in 2018 it is still a major health problem. Since 2011, anti-HCV therapy with availability of direct-acting antiviral drugs has revolutionized the clinical response and paved the way to eradication strategies. However, despite th...
保存先:
| 出版年: | Clin Mol Hepatol |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Association for the Study of the Liver
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6435970/ https://ncbi.nlm.nih.gov/pubmed/30669818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2018.0061 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|